These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 34094676)

  • 41. Multiple mechanisms deregulate EZH2 and histone H3 lysine 27 epigenetic changes in myeloid malignancies.
    Khan SN; Jankowska AM; Mahfouz R; Dunbar AJ; Sugimoto Y; Hosono N; Hu Z; Cheriyath V; Vatolin S; Przychodzen B; Reu FJ; Saunthararajah Y; O'Keefe C; Sekeres MA; List AF; Moliterno AR; McDevitt MA; Maciejewski JP; Makishima H
    Leukemia; 2013 Jun; 27(6):1301-9. PubMed ID: 23486531
    [TBL] [Abstract][Full Text] [Related]  

  • 42. EZH2-mediated epigenetic silencing of TIMP2 promotes ovarian cancer migration and invasion.
    Yi X; Guo J; Guo J; Sun S; Yang P; Wang J; Li Y; Xie L; Cai J; Wang Z
    Sci Rep; 2017 Jun; 7(1):3568. PubMed ID: 28620234
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Overexpression of EZH2 contributes to acquired cisplatin resistance in ovarian cancer cells in vitro and in vivo.
    Hu S; Yu L; Li Z; Shen Y; Wang J; Cai J; Xiao L; Wang Z
    Cancer Biol Ther; 2010 Oct; 10(8):788-95. PubMed ID: 20686362
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Overexpression of HMGA1 deregulates tumor growth via cdc25A and alters migration/invasion through a cdc25A-independent pathway in medulloblastoma.
    Lau KM; Chan QK; Pang JC; Ma FM; Li KK; Yeung WW; Cheng AS; Feng H; Chung NY; Li HM; Zhou L; Wang Y; Mao Y; Ng HK
    Acta Neuropathol; 2012 Apr; 123(4):553-71. PubMed ID: 22249617
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Automethylation of PRC2 promotes H3K27 methylation and is impaired in H3K27M pediatric glioma.
    Lee CH; Yu JR; Granat J; Saldaña-Meyer R; Andrade J; LeRoy G; Jin Y; Lund P; Stafford JM; Garcia BA; Ueberheide B; Reinberg D
    Genes Dev; 2019 Oct; 33(19-20):1428-1440. PubMed ID: 31488577
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Multifaceted role of the polycomb-group gene EZH2 in hematological malignancies.
    Sashida G; Iwama A
    Int J Hematol; 2017 Jan; 105(1):23-30. PubMed ID: 27830540
    [TBL] [Abstract][Full Text] [Related]  

  • 47. TGF-β1 induces HMGA1 expression in human breast cancer cells: implications of the involvement of HMGA1 in TGF-β signaling.
    Zu X; Zhong J; Tan J; Tan L; Yang D; Zhang Q; Ding W; Liu W; Wen G; Liu J; Cao R; Jiang Y
    Int J Mol Med; 2015 Mar; 35(3):693-701. PubMed ID: 25572132
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Epigenetic regulation of cell adhesion and communication by enhancer of zeste homolog 2 in human endothelial cells.
    Dreger H; Ludwig A; Weller A; Stangl V; Baumann G; Meiners S; Stangl K
    Hypertension; 2012 Nov; 60(5):1176-83. PubMed ID: 22966008
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Overexpression of HMGA1 promotes anoikis resistance and constitutive Akt activation in pancreatic adenocarcinoma cells.
    Liau SS; Jazag A; Ito K; Whang EE
    Br J Cancer; 2007 Mar; 96(6):993-1000. PubMed ID: 17342093
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Polycomb Ezh2 methyltransferase regulates muscle gene expression and skeletal muscle differentiation.
    Caretti G; Di Padova M; Micales B; Lyons GE; Sartorelli V
    Genes Dev; 2004 Nov; 18(21):2627-38. PubMed ID: 15520282
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Architectural Chromatin Factor High Mobility Group A1 Enhances DNA Ligase IV Activity Influencing DNA Repair.
    Pellarin I; Arnoldo L; Costantini S; Pegoraro S; Ros G; Penzo C; Triolo G; Demarchi F; Sgarra R; Vindigni A; Manfioletti G
    PLoS One; 2016; 11(10):e0164258. PubMed ID: 27723831
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Transcriptional Regulation of Glucose Metabolism: The Emerging Role of the HMGA1 Chromatin Factor.
    Chiefari E; Foti DP; Sgarra R; Pegoraro S; Arcidiacono B; Brunetti FS; Greco M; Manfioletti G; Brunetti A
    Front Endocrinol (Lausanne); 2018; 9():357. PubMed ID: 30034366
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Overexpression of polycomb repressive complex 2 key components EZH2/SUZ12/EED as an unfavorable prognostic marker in cholangiocarcinoma.
    Wasenang W; Puapairoj A; Settasatian C; Proungvitaya S; Limpaiboon T
    Pathol Res Pract; 2019 Jul; 215(7):152451. PubMed ID: 31126817
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Chromatin regulator PRC2 is a key regulator of epigenetic plasticity in glioblastoma.
    Natsume A; Ito M; Katsushima K; Ohka F; Hatanaka A; Shinjo K; Sato S; Takahashi S; Ishikawa Y; Takeuchi I; Shimogawa H; Uesugi M; Okano H; Kim SU; Wakabayashi T; Issa JP; Sekido Y; Kondo Y
    Cancer Res; 2013 Jul; 73(14):4559-70. PubMed ID: 23720055
    [TBL] [Abstract][Full Text] [Related]  

  • 55. RNA-Mediated Regulation of HMGA1 Function.
    Benecke AG; Eilebrecht S
    Biomolecules; 2015; 5(2):943-57. PubMed ID: 26117853
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Epigenetic analysis of FHL1 tumor suppressor gene in human liver cancer.
    Wang J; Huang F; Huang J; Kong J; Liu S; Jin J
    Oncol Lett; 2017 Nov; 14(5):6109-6116. PubMed ID: 29113254
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hmga1/Hmga2 double knock-out mice display a "superpygmy" phenotype.
    Federico A; Forzati F; Esposito F; Arra C; Palma G; Barbieri A; Palmieri D; Fedele M; Pierantoni GM; De Martino I; Fusco A
    Biol Open; 2014 Apr; 3(5):372-8. PubMed ID: 24728959
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Overexpression of HMGA1 confers radioresistance by transactivating RAD51 in cholangiocarcinoma.
    Song J; Cui D; Wang J; Qin J; Wang S; Wang Z; Zhai X; Ma H; Ma D; Liu Y; Jin B; Liu Z
    Cell Death Discov; 2021 Oct; 7(1):322. PubMed ID: 34716319
    [TBL] [Abstract][Full Text] [Related]  

  • 59. High Mobility Group A 1 Expression as a Poor Prognostic Marker Associated with Tumor Invasiveness in Gastric Cancer.
    Chang HP; Sun JT; Cheng CY; Liang YJ; Chen YL
    Life (Basel); 2022 May; 12(5):. PubMed ID: 35629376
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Epigenetic therapy leaps ahead with specific targeting of EZH2.
    Melnick A
    Cancer Cell; 2012 Nov; 22(5):569-70. PubMed ID: 23153531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.